These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27145396)

  • 1. Clinical and Quality of Life Outcomes of Speech Treatment for Parkinson's Disease Delivered to the Home Via Telerehabilitation: A Noninferiority Randomized Controlled Trial.
    Theodoros DG; Hill AJ; Russell TG
    Am J Speech Lang Pathol; 2016 May; 25(2):214-32. PubMed ID: 27145396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing disordered speech and voice in Parkinson's disease: a telerehabilitation application.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2010; 45(6):630-44. PubMed ID: 20102257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.
    Sackley CM; Rick C; Au P; Brady MC; Beaton G; Burton C; Caulfield M; Dickson S; Dowling F; Hughes M; Ives N; Jowett S; Masterson-Algar P; Nicoll A; Patel S; Smith CH; Woolley R; Clarke CE;
    Trials; 2020 May; 21(1):436. PubMed ID: 32460885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analysis of home telerehabilitation for speech treatment in people with Parkinson's disease.
    Saiyed M; Hill AJ; Russell TG; Theodoros DG; Scuffham P
    J Telemed Telecare; 2022 Aug; 28(7):524-529. PubMed ID: 32847466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voice telerehabilitation in Parkinson's disease.
    Dias AE; Limongi JC; Barbosa ER; Hsing WT
    Codas; 2016 Apr; 28(2):176-81. PubMed ID: 27191882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trial.
    Sackley CM; Smith CH; Rick C; Brady MC; Ives N; Patel R; Roberts H; Dowling F; Jowett S; Wheatley K; Patel S; Kelly D; Sands G; Clarke C
    Trials; 2014 Jun; 15():213. PubMed ID: 24908096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivering group speech maintenance therapy via telerehabilitation to people with Parkinson's disease: A pilot study.
    Quinn R; Park S; Theodoros D; Hill AJ
    Int J Speech Lang Pathol; 2019 Aug; 21(4):385-394. PubMed ID: 29879854
    [No Abstract]   [Full Text] [Related]  

  • 9. Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial.
    Sackley CM; Rick C; Brady MC; Woolley R; Burton C; Patel S; Masterson-Algar P; Nicoll A; Smith CH; Jowett S; Ives N; Beaton G; Dickson S; Ottridge R; Sharp L; Nankervis H; Clarke CE;
    BMJ; 2024 Jul; 386():e078341. PubMed ID: 38986549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telerehabilitation for Lee Silverman Voice Treatment (Tele-LSVT)-Loud on voice intensity and voice use in daily living in people with multiple sclerosis: A protocol for a feasibility and pilot randomized controlled study.
    Vitali C; Fusari G; Baldanzi C; Cacciatore DM; Crispiatico V; Carullo A; Rovaris M; Cattaneo D; Baglio F; Isernia S
    Digit Health; 2023; 9():20552076231218150. PubMed ID: 38074343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based treatment of voice and speech disorders in Parkinson disease.
    Mahler LA; Ramig LO; Fox C
    Curr Opin Otolaryngol Head Neck Surg; 2015 Jun; 23(3):209-15. PubMed ID: 25943966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease.
    Halpern AE; Ramig LO; Matos CE; Petska-Cable JA; Spielman JL; Pogoda JM; Gilley PM; Sapir S; Bennett JK; McFarland DH
    Am J Speech Lang Pathol; 2012 Nov; 21(4):354-67. PubMed ID: 23071195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory Responses to Two Voice Interventions for Parkinson's Disease.
    Richardson K; Huber JE; Kiefer B; Kane C; Snyder S
    J Speech Lang Hear Res; 2022 Oct; 65(10):3730-3748. PubMed ID: 36167066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of vocal symptoms in Parkinson's disease: the Lee Silverman method].
    Dias AE; Limongi JC
    Arq Neuropsiquiatr; 2003 Mar; 61(1):61-6. PubMed ID: 12715021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technology-enabled management of communication and swallowing disorders in Parkinson's disease: a systematic scoping review.
    Theodoros D; Aldridge D; Hill AJ; Russell T
    Int J Lang Commun Disord; 2019 Mar; 54(2):170-188. PubMed ID: 29923267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
    Wight S; Miller N
    Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crowdsourced Perceptual Ratings of Voice Quality in People With Parkinson's Disease Before and After Intensive Voice and Articulation Therapies: Secondary Outcome of a Randomized Controlled Trial.
    McAllister T; Nightingale C; Moya-Galé G; Kawamura A; Ramig LO
    J Speech Lang Hear Res; 2023 May; 66(5):1541-1562. PubMed ID: 37059078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of PD Check-In on self-management skills for maintenance of speech after intensive treatment.
    Finnimore A; Theodoros D; Rumbach AF
    Int J Lang Commun Disord; 2024; 59(4):1628-1646. PubMed ID: 38377119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment.
    Ramig LO; Fox C; Sapir S
    Semin Speech Lang; 2004 May; 25(2):169-80. PubMed ID: 15118943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.